A PROSPECTIVE OBSERVATIONAL STUDY TO EVALUATE PREDICTORS OF CLINICAL EFFECTIVENESS IN RESPONSE TO OMALIZUMAB

Project: Other project

StatusFinished
Effective start/end date3/27/143/26/17

Funding

  • Genentech, Inc.: $3,280.00